Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermAssetCharges,longTermInvestments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,dividendsPaid,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,investments,otherCashflowsFromInvestingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,marketState,trailingAnnualDividendYield,epsTrailingTwelveMonths,epsForward,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,exchange,priceHint,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,MRK.DE,-5390000000.0,129242000,574000000,,984000000,67000000,747000000,1280000000,2910000000,1049000000,1049000000,7000000,-84000000,,,,236000000,4631000000,3582000000,1721000000,-65000000,,748000000,747000000,7765000000.0,3814000000.0,24908000000.0,18916000000.0,4594000000.0,43891000000.0,565000000.0,1203000000.0,15200000000.0,5255000000.0,16541000000.0,-663000000.0,2416000000.0,2238000000.0,10652000000.0,2556000000.0,-663000000.0,6552000000.0,10617000000.0,60000000.0,3654000000.0,8561000000.0,3462000000.0,2711000000.0,,,334000000.0,-346000000.0,61000000.0,6000000.0,126000000.0,883000000.0,7000000.0,1216000000.0,424000000.0,-48000000.0,-108000000.0,-314000000.0,-7000000.0,7000000.0,-315000000.0,,,-35000000.0,en-US,US,EQUITY,False,Delayed Quote,1.1335648,202.8 - 206.5,202.9,205.1,205.2,67,112,finmb_596117,XETRA,MERCK Kommanditgesellschaft auf Aktien,EUR,314841,280626,91.149994,0.7992108,114.05 - 207.6,-2.4000092,-0.011560737,114.05,207.6,1636592400,1636592400,1636592400,1.4,44.90153,7200000,False,False,EUR,REGULAR,0.006899951,4.57,6.76,38.976,184.98143,20.218567,0.109300524,155.84508,49.35492,0.3166922,89216442368,30.355028,5.264778,15,Europe/Berlin,CEST,MERCK KGAA,205.2,1630578683,2.300003,203.0,206.5,202.8,92713,0,GER,2,de_market,0.49,,,207.6,114.05,184.98,155.85,314.84k,280.63k,129.24M,,129.1M,0.00%,61.49%,,,,,,1.4,0.87%,1.40,0.69%,1.20,24.81%,,"Apr 26, 2021",2:1,"Jun 30, 2014","Dec 31, 2020","Mar 31, 2021",12.80%,19.21%,4.82%,12.15%,17.8B,40.93,6.00%,10.75B,4.93B,2.28B,4.57,63.80%,2.3B,5.29,12.35B,65.05,1.00,38.98,4.18B,2.59B,Value,64293,Healthcare,57850,9,5,"MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",Darmstadt,49 6151 72 0,7,1609372800,1625011200,8,Germany,http://www.merckgroup.com,86400,9,Frankfurter Strasse 250,49 6151 72 5577,Drug Manufacturers—Specialty & Generic
t-1,MRK.DE,-6666000000.0,129242000,632000000,,560000000,71000000,436000000,1343000000,2856000000,705000000,705000000,171000000,-1000000,,,,119000000,4598000000,3893000000,1742000000,-145000000,,441000000,436000000,7653000000.0,3814000000.0,24779000000.0,16946000000.0,4503000000.0,41796000000.0,565000000.0,189000000.0,14452000000.0,5763000000.0,15959000000.0,-1885000000.0,1944000000.0,1355000000.0,9231000000.0,1228000000.0,-1885000000.0,6421000000.0,9280000000.0,1000000.0,4278000000.0,9458000000.0,3294000000.0,1095000000.0,1543000000.0,539000000.0,-5000000.0,-98000000.0,-1381000000.0,-1381000000.0,136000000.0,-192000000.0,-1000000.0,1288000000.0,345000000.0,-48000000.0,110000000.0,170000000.0,-7000000.0,14000000.0,-636000000.0,-7000000.0,502000000.0,49000000.0,en-US,US,EQUITY,False,Delayed Quote,1.1335648,202.8 - 206.5,202.9,205.1,205.2,67,112,finmb_596117,XETRA,MERCK Kommanditgesellschaft auf Aktien,EUR,314841,280626,91.149994,0.7992108,114.05 - 207.6,-2.4000092,-0.011560737,114.05,207.6,1636592400,1636592400,1636592400,1.4,44.90153,7200000,False,False,EUR,REGULAR,0.006899951,4.57,6.76,38.976,184.98143,20.218567,0.109300524,155.84508,49.35492,0.3166922,89216442368,30.355028,5.264778,15,Europe/Berlin,CEST,MERCK KGAA,205.2,1630578683,2.300003,203.0,206.5,202.8,92713,0,GER,2,de_market,0.49,,,207.6,114.05,184.98,155.85,314.84k,280.63k,129.24M,,129.1M,0.00%,61.49%,,,,,,1.4,0.87%,1.40,0.69%,1.20,24.81%,,"Apr 26, 2021",2:1,"Jun 30, 2014","Dec 31, 2020","Mar 31, 2021",12.80%,19.21%,4.82%,12.15%,17.8B,40.93,6.00%,10.75B,4.93B,2.28B,4.57,63.80%,2.3B,5.29,12.35B,65.05,1.00,38.98,4.18B,2.59B,Value,64293,Healthcare,57850,9,5,"MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",Darmstadt,49 6151 72 0,7,1609372800,1625011200,8,Germany,http://www.merckgroup.com,86400,9,Frankfurter Strasse 250,49 6151 72 5577,Drug Manufacturers—Specialty & Generic
t-2,MRK.DE,-6756000000.0,129242000,531000000,,1064000000,67000000,805000000,1272000000,2671000000,802000000,802000000,66000000,-109000000,,,,258000000,4447000000,3645000000,1776000000,262000000,,806000000,805000000,8172000000.0,3814000000.0,25236000000.0,17928000000.0,4236000000.0,43231000000.0,565000000.0,1099000000.0,14579000000.0,5550000000.0,16512000000.0,-1030000000.0,1604000000.0,1548000000.0,9709000000.0,2699000000.0,-1030000000.0,6027000000.0,10258000000.0,85000000.0,4098000000.0,9454000000.0,3428000000.0,1684000000.0,1487000000.0,658000000.0,54000000.0,-738000000.0,-380000000.0,-380000000.0,-142000000.0,36000000.0,-17000000.0,1170000000.0,450000000.0,-48000000.0,51000000.0,-75000000.0,-7000000.0,27000000.0,-237000000.0,37000000.0,-500000000.0,549000000.0,en-US,US,EQUITY,False,Delayed Quote,1.1335648,202.8 - 206.5,202.9,205.1,205.2,67,112,finmb_596117,XETRA,MERCK Kommanditgesellschaft auf Aktien,EUR,314841,280626,91.149994,0.7992108,114.05 - 207.6,-2.4000092,-0.011560737,114.05,207.6,1636592400,1636592400,1636592400,1.4,44.90153,7200000,False,False,EUR,REGULAR,0.006899951,4.57,6.76,38.976,184.98143,20.218567,0.109300524,155.84508,49.35492,0.3166922,89216442368,30.355028,5.264778,15,Europe/Berlin,CEST,MERCK KGAA,205.2,1630578683,2.300003,203.0,206.5,202.8,92713,0,GER,2,de_market,0.49,,,207.6,114.05,184.98,155.85,314.84k,280.63k,129.24M,,129.1M,0.00%,61.49%,,,,,,1.4,0.87%,1.40,0.69%,1.20,24.81%,,"Apr 26, 2021",2:1,"Jun 30, 2014","Dec 31, 2020","Mar 31, 2021",12.80%,19.21%,4.82%,12.15%,17.8B,40.93,6.00%,10.75B,4.93B,2.28B,4.57,63.80%,2.3B,5.29,12.35B,65.05,1.00,38.98,4.18B,2.59B,Value,64293,Healthcare,57850,9,5,"MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",Darmstadt,49 6151 72 0,7,1609372800,1625011200,8,Germany,http://www.merckgroup.com,86400,9,Frankfurter Strasse 250,49 6151 72 5577,Drug Manufacturers—Specialty & Generic
t-3,MRK.DE,-7800000000.0,129242000,520000000,,391000000,44000000,290000000,1333000000,2509000000,621000000,621000000,35000000,-107000000,,,,100000000,4119000000,3498000000,1610000000,-230000000,,291000000,290000000,8664000000.0,3814000000.0,25796000000.0,17982000000.0,4227000000.0,43822000000.0,565000000.0,585000000.0,13779000000.0,5635000000.0,17118000000.0,-176000000.0,1574000000.0,1512000000.0,10080000000.0,2741000000.0,-176000000.0,6067000000.0,9726000000.0,32000000.0,4060000000.0,9659000000.0,3537000000.0,1764000000.0,1462000000.0,673000000.0,-69000000.0,-216000000.0,321000000.0,-302000000.0,-220000000.0,-18000000.0,-3000000.0,502000000.0,436000000.0,-623000000.0,-118000000.0,75000000.0,-7000000.0,108000000.0,-200000000.0,26000000.0,-1000000.0,-354000000.0,en-US,US,EQUITY,False,Delayed Quote,1.1335648,202.8 - 206.5,202.9,205.1,205.2,67,112,finmb_596117,XETRA,MERCK Kommanditgesellschaft auf Aktien,EUR,314841,280626,91.149994,0.7992108,114.05 - 207.6,-2.4000092,-0.011560737,114.05,207.6,1636592400,1636592400,1636592400,1.4,44.90153,7200000,False,False,EUR,REGULAR,0.006899951,4.57,6.76,38.976,184.98143,20.218567,0.109300524,155.84508,49.35492,0.3166922,89216442368,30.355028,5.264778,15,Europe/Berlin,CEST,MERCK KGAA,205.2,1630578683,2.300003,203.0,206.5,202.8,92713,0,GER,2,de_market,0.49,,,207.6,114.05,184.98,155.85,314.84k,280.63k,129.24M,,129.1M,0.00%,61.49%,,,,,,1.4,0.87%,1.40,0.69%,1.20,24.81%,,"Apr 26, 2021",2:1,"Jun 30, 2014","Dec 31, 2020","Mar 31, 2021",12.80%,19.21%,4.82%,12.15%,17.8B,40.93,6.00%,10.75B,4.93B,2.28B,4.57,63.80%,2.3B,5.29,12.35B,65.05,1.00,38.98,4.18B,2.59B,Value,64293,Healthcare,57850,9,5,"MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",Darmstadt,49 6151 72 0,7,1609372800,1625011200,8,Germany,http://www.merckgroup.com,86400,9,Frankfurter Strasse 250,49 6151 72 5577,Drug Manufacturers—Specialty & Generic
